Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

@article{Kalliomki2001ProbioticsIP,
  title={Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial},
  author={Marko Kalliom{\"a}ki and Seppo Salminen and Heikki S Arvilommi and Pentti O. Kero and Pertti J Koskinen and Erika Isolauri},
  journal={The Lancet},
  year={2001},
  volume={357},
  pages={1076-1079}
}
View on Elsevier
allderm.com
2,344 Citations
Highly Influential Citations
44
Background Citations
585
Methods Citations
30
Results Citations
70

Figures and Tables from this paper

2,344 Citations

PRO AND ANTI: THE BIOTICS OF ALLERGIC DISEASE

Gut microflora might be a hitherto unexplored source of natural immunomodulators and probiotics for prevention of atopic disease in children at high risk.

PRO AND ANTI: THE BIOTICS OF ALLERGIC DISEASE

Gut microflora might be a hitherto unexplored source of natural immunomodulators and probiotics for prevention of atopic disease in children at high risk.

PANDA STUDY Probiotics AND Allergy Primary prevention of asthma and allergy by supplementation of probiotics in early life

  • Biology
  • 2015
Exposure of pregnant women with previous or recent atopic disease, and their offspring to probiotics has been suggested, and it is likely that antigen-presenting cells (APC's) are involved, since these cells are important in the first line of defence in the gastrointestinal tract.

Perinatal probiotic supplementation in the prevention of allergy related disease: 6 year follow up of a randomised controlled trial

Maternal probiotic ingestion alone may be sufficient for long term reduction in the cumulative incidence of AD, but not other allergy related diseases.

Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial

Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial.

Atopic dermatitis and skin disease A differential effect of 2 probiotics in the prevention of eczema and atopy : A double-blind , randomized , placebo-controlled trial

A double-blind, randomized placebo-controlled trial of infants at risk of allergic disease to determine whether probiotic supplementation in early life could prevent development of eczema and atopy at 2 years.

Probiotics: on-going research on atopic individuals

The regulatory role of probiotics in human allergic disease was first emphasised in the demonstration of a suppressive effect on lymphocyte proliferation and interleukin-4 generation in vitro, and a significant improvement in the clinical course of atopic eczema was reported in infants given a probiotic-supplemented diet.

Probiotics in the Treatment and Prevention of Allergies in Children

It is inferred that probiotics induce systemically detectable low-grade inflammation, which may explain the clinical effects and the secretion pattern of cytokines induced by PBMC, andications from studies of feces and blood at the age 6 months suggest that probiotic may enhance both inflammation and immune defence of the gut.

Probiotics in the Treatment and Prevention of Allergy in Children

Results on randomized, controlled studies in which childhood atopic eczema was treated or which aimed to prevent development of allergy during childhood are reported.
...

References

SHOWING 1-10 OF 112 REFERENCES

Probiotics in primary prevention of atopic disease: a randomised placebo‐controlled trial.

Gut microflora might be a hitherto unexplored source of natural immunomodulators and probiotics, for prevention of atopic disease in children at high risk.

Probiotics: a novel approach in the management of food allergy.

Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey

Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing.

Differences in the neonatal gut microflora precede the development of atopy, suggesting a crucial role of the balance of indigenous intestinal bacteria for the maturation of human immunity to a nonatopic mode.

Atopic diseases in infancy. The German multicenter atopy study (MAS‐90)

  • R. BergmannK. Bergmann U. Wahn
  • Medicine
    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
  • 1994
The German Multicenter Atopy Study (MAS-90) was initiated to evaluate the predictive value of various clinical and immunological parameters as well as the significance of early environmental exposures to allergens and trigger factors for the development of atopic diseases in early childhood.

Immune and clinical impact of Lactobacillus acidophilus on asthma.

  • J. G. WheelerS. Shema R. Helm
  • Medicine
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • 1997

Early childhood infection and atopic disorder

Interpretation of the prediction of atopic disorders by immunisation with whole-cell pertussis vaccine and treatment with oral antibiotics needs to be very cautious because of the possibilities of confounding effects and reverse causation.

Role of microbial burden in aetiology of allergy and asthma

Natural course of sensitization to food and inhalant allergens during the first 6 years of life.

Atopy in children of families with an anthroposophic lifestyle

...